Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 1,542 | 1,558 | 1,542 |
| Gross Profit | 945 | 970 | 885 |
| Operating Income | 197 | 239 | 112 |
| Net Income | 169 | 181 | 68 |
| EBITDA | 366 | 385 | 256 |
| EPS Diluted | 1.98 | 2.16 | 0.84 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 513 | 457 | 276 |
| Total Current Assets | 1,154 | 1,161 | 1,058 |
| Total Assets | 3,782 | 3,890 | 3,782 |
| Total Current Liabilities | 340 | 321 | 307 |
| Total Liabilities | 2,098 | 2,085 | 2,194 |
| Total Equity | 1,685 | 1,804 | 1,588 |
| Total Debt | 1,666 | 1,630 | 1,682 |
| Net Debt | 1,153 | 1,173 | 1,405 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 312 | 264 | 140 |
| Capital Expenditure | -48 | -47 | -67 |
| Free Cash Flow | 264 | 217 | 73 |
| Stock-Based Comp | 36 | 28 | 20 |
| Net Change in Cash | 43 | -57 | -180 |